These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25282897)

  • 1. [Effect of Buzhong Yiqi decoction on PI3K and AKT in spleen, stomach and lung of nude mice with lung adenocarcinoma transplantation tumor].
    Liu YL; Wang Y; Yi JL; Jing H; Liu CY
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(10):1869-73. PubMed ID: 25282897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of Buzhong Yiqi decoction on expression of Bad, NF-κB, caspase-9, Survivin, and mTOR in nude mice with A549/DDP transplantation tumors].
    Liu YL; Yi JL; Liu CY
    Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(4):725-730. PubMed ID: 28959844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Buzhong yiqi decoction containing serum reversed resistance of A549/DDP to cisplatin and its effect on the expression of survivin: an experimental research ].
    Yi JL; Wang Y; Jing H; Shi YT; Liu CY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1250-5. PubMed ID: 25509271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of Yiqi Chutan Formula in Suppressing A549 Lung Cancer by Regulating Unfolded Protein Response].
    Liu QO; Wang SM; Li S
    Zhong Yao Cai; 2016 Mar; 39(3):625-9. PubMed ID: 30091359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of serums containing Buzhong Yiqi decoction with Astragalus Radix or Hedysari Radix on anti-immunosenescence in spleen lymphocytes of SAMP8 mice].
    Zhang GL; Cheng WD; Zhang WJ; Li W; Li Q
    Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(15):2888-2894. PubMed ID: 28914034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of Buzhong Yiqi decoction in patients with spleen and stomach qi deficiency after routine surgery and chemotherapy for colorectal cancer.
    Hu Q; Chen XP; Tang ZJ; Zhu XY; Liu C
    World J Gastrointest Surg; 2024 Jul; 16(7):2183-2193. PubMed ID: 39087096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
    Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
    Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Viqi Chutan Recipe on Caspase-4 and DNA-PK of Cell Apoptosis Approach in Transplanted Lung Cancer A549 Cells in Nude Mice].
    Li S; Wang SM; Yang YB; Liu QO
    Zhong Yao Cai; 2015 Jun; 38(6):1247-50. PubMed ID: 26762068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating network pharmacology and experimental verification to investigate the pharmacological mechanisms of Buzhong Yiqi decoction in the treatment of non-small cell lung cancer.
    Zeng P; Wang F; Zhang J; Ur Rashid H; Li X; Zhang P; Luo Y; Wu X
    Chem Biol Drug Des; 2024 Jan; 103(1):e14414. PubMed ID: 38230796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systematic review and Meta-analysis on efficacy and safety of Buzhong Yiqi Decoction for stable chronic obstructive pulmonary disease].
    Yi-Ling F; Qing M; Xing L; Chang-Zheng F; Mao-Rong F; Qing C; Ning W; Qiu-Xiao MA; Ya-Ni H
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5344-5355. PubMed ID: 33350193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
    Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation.
    Wu DW; Wu TC; Chen CY; Lee H
    Clin Cancer Res; 2016 Nov; 22(21):5370-5382. PubMed ID: 27178741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of radiosensitivity of lung adenocarcinoma using a decoction from the Fuzhengzengxiao formula.
    Zhang Q; Wu T; Lei Y; Li B; Liu W; Tian Y; Zhao W; Huang J
    J Tradit Chin Med; 2015 Dec; 35(6):690-6. PubMed ID: 26742316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of modified Buzhong Yiqi decoction combined with pelvic floor muscle exercise-biofeedback-electrical stimulation on early stage postpartum pelvic floor dysfunction].
    Chen Z; Huang H; Chen QY
    Zhongguo Zhong Yao Za Zhi; 2018 Jun; 43(11):2391-2395. PubMed ID: 29945396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma.
    Zhuang H; Bai J; Chang JY; Yuan Z; Wang P
    Oncotarget; 2016 Dec; 7(51):84688-84694. PubMed ID: 27713162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Buzhong Yiqi Decoction Combined with THP Bladder Perfusion on Postoperative Efficacy in Patients with Bladder Cancer.
    Wang Y; Zhang Y; Liu Z; Li Q; Jin H
    Evid Based Complement Alternat Med; 2021; 2021():3685213. PubMed ID: 34804176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
    Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hospital-acquired pneumonia with multi-drug resistant organism by Buzhong Yiqi decoction based on Fuzheng Quxie classical prescription: study protocol for a randomized controlled trial.
    Deng D; Chen Z; Jia L; Bu J; Ye M; Sun L; Gen Y; Zhang W; Chen G; Fang B
    Trials; 2019 Dec; 20(1):817. PubMed ID: 31888702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
    Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
    Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.